Cancer
Dr. Azura Deniel, a Consultant Clinical Oncologist, has made precision therapies and compassionate support available at Ampang Puteri Specialist Hospital (APSH) in Malaysia, an attractive option for Bangladeshi patients seeking advanced cancer treatment abroad. By tailoring treatment plans to each patient's unique cancer profile, Dr. Azura aims to
Cancer
Research from Shandong University of Traditional Chinese Medicine sheds light on the critical interaction between endometrial cancer cells and tumour-associated macrophages mediated by extracellular vesicles. This interaction plays a crucial role in the proliferation, migration, and invasion of cancer cells, as well as in the polarization of macrophages towards an
Cancer
Researchers at Fudan University in Shanghai, China have identified a key mechanism by which endometrial cancer cells evade the immune system and resist immunotherapy. The study, published in the Journal for ImmunoTherapy of Cancer, found that the enzyme O-GlcNAc transferase (OGT) plays a critical role in promoting immune evasion and
Cancer
Investigators at the University of Texas MD Anderson Cancer Center have published a report comparing the outcomes of matched unrelated donor (MUD) and haploidentical donor hematopoietic cell transplantation (HCT) using post-transplant cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis. The study, which included 5,873 adult patients who received MUD (n=
Cancer
Research published in Laboratory Investigation presents findings on the heterogeneity of human epidermal growth factor receptor 2 (HER2) in endometrial cancer. The study, conducted at Emory University Hospital, aimed to evaluate HER2 heterogeneity at the protein and gene levels in nonserous endometrial carcinomas. The research revealed significant intratumoral heterogeneity in
Cancer
A new study published in the Journal of Managed Care & Specialty Pharmacy has examined the real-world patient profile and step-up dosing process of early initiators of teclistamab for multiple myeloma in US hospitals. The research, conducted by investigators at Memorial Sloan-Kettering Cancer Center, analyzed data from the Premier Healthcare
Cancer
Research conducted by the National Cancer Institute (NCI) has shown that cancer risk among people with HIV (PWH) has varied across different racial/ethnic and transmission risk groups. The study, which analyzed data from PWH aged 20 years during 2001-2019, found significant differences in cancer incidence rates among different racial/
Cancer
Research from Chongqing University Cancer Hospital in China has uncovered a crucial link between HIV reservoirs and the development of lymphoma in people living with HIV (PLWH). Despite advancements in antiretroviral therapy, PLWH remain at high risk of lymphoma, with HIV reservoirs playing a significant role in lymphomagenesis. The study&
Cancer
Local Specsavers store in Mexborough partnered with Macmillan Cancer Support for their World's Biggest Coffee Morning, a charity event that has raised over £310 million since its inception in 1990. The Specsavers team baked homemade cakes and hosted a cake sale, donating the proceeds to the charity. Store
Cancer
Colleagues from Travis Perkins Managed Services came together for a charity netball tournament, playing 39 matches and raising a significant amount for Bowel Cancer UK. The event was organized in tribute to Dan Trasler, a colleague who passed away from the disease in April. The mixed netball format was chosen
Cancer
The construction of a new cancer care building at Tata Memorial Centre's Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Navi Mumbai has commenced, marking a significant milestone in the collaborative effort between ICICI Bank and TMC. Funded by ICICI Bank's CSR contribution
Biomedical engineering
RNA-based immunotherapies have gained significant attention in recent years due to their potential in reprogramming the immune system to combat cancer. A recent study published in Nature Biomedical Engineering has made groundbreaking discoveries that have led to the development of a new class of RNA therapeutics called Universal Immune Fortifying
